» Articles » PMID: 30505577

Study of Gene Expression in Colorectal Cancer

Overview
Date 2018 Dec 4
PMID 30505577
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Cofilin is a key regulatory protein in the dynamics of actin filaments. Previous studies have shown cofilin 1's major role in cell migration process and its role in tumor cell migration and invasion. Therefore, cofilin 1 may have the potential as a novel diagnostic tumor marker in various cancers. In this study, differential expression of CFL1 in CRC tissues in comparison with adjacent non-tumor tissues was investigated and the diagnostic value of this protein in CRC was evaluated.

Methods: Synthesized cDNA from extracted RNAs of 30 patients were subjected to qRT-PCR to quantify relative expression of cofilin 1. The relationship between cofilin 1 expression and clinicopathological features of patients were studied too.

Results: The study showed significant upregulation of cofilin 1 in CRC tissue samples compared to adjacent non-tumor tissue samples (P<0.05). The receiver operating characteristic curve analysis showed higher area under the curve (0.85). There was no significant correlation between cofilin 1 expression levels and clinicopathological features of patients.

Conclusions: According to the obtained results, cofilin 1 can serve as a candidate for clinically useful diagnostic biomarker or therapeutic target for CRC.

Citing Articles

CFL1 is Implicated in Chronic Myeloid Leukemia Response during Imatinib Therapy.

Yin X, Li X, Jiang H, Lin X, Ma Z, Chen X J Cancer. 2024; 15(8):2424-2430.

PMID: 38495482 PMC: 10937266. DOI: 10.7150/jca.92202.


Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives.

Kielb P, Kowalczyk K, Gurwin A, Nowak L, Krajewski W, Sosnowski R Biomedicines. 2023; 11(6).

PMID: 37371647 PMC: 10295349. DOI: 10.3390/biomedicines11061552.


Proteomic Markers for Mechanobiological Properties of Metastatic Cancer Cells.

Leonov S, Inyang O, Achkasov K, Bogdan E, Kontareva E, Chen Y Int J Mol Sci. 2023; 24(5).

PMID: 36902201 PMC: 10003476. DOI: 10.3390/ijms24054773.


A novel matrine derivative, WM130, inhibits activation and movement of human hepatic stellate LX-2 cells by targeting cofilin 1.

Xu Y, Duan J, Ji W, Liu C, Li X, Wu Q Cytotechnology. 2022; 74(6):613-622.

PMID: 36389285 PMC: 9652194. DOI: 10.1007/s10616-022-00548-w.


A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer.

Mogal M, Junayed A, Mahmod M, Sompa S, Lima S, Kar N Biomed Res Int. 2022; 2022:1617989.

PMID: 35547358 PMC: 9085308. DOI: 10.1155/2022/1617989.


References
1.
Shroff J, Thosani N, Batra S, Singh H, Guha S . Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol. 2015; 20(48):18466-76. PMC: 4277988. DOI: 10.3748/wjg.v20.i48.18466. View

2.
Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A . The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol. 2006; 173(3):395-404. PMC: 2063840. DOI: 10.1083/jcb.200510115. View

3.
Yap C, Simpson T, Pratt T, Price D, Maciver S . The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton. 2005; 60(3):153-65. DOI: 10.1002/cm.20053. View

4.
Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Iizuka N . Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues. Oncol Rep. 2011; 26(6):1595-9. DOI: 10.3892/or.2011.1447. View

5.
Nagaoka R, Abe H, Kusano K, Obinata T . Concentration of cofilin, a small actin-binding protein, at the cleavage furrow during cytokinesis. Cell Motil Cytoskeleton. 1995; 30(1):1-7. DOI: 10.1002/cm.970300102. View